Imvax

Philadelphia, United States

Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.

$29.0M raised

Jan 2025

Venture - Series Unknown

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Imvax raised?

Imvax has raised $29.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in January 2025.

Who are Imvax's investors?

Imvax's investors include Invus, Magnetar Capital, Ziff Capital Partners, TLP Investment Partners, WILD Group Management.

Where is Imvax headquartered?

Imvax is headquartered in Philadelphia, United States.

What does Imvax do?

Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.

What stage is Imvax at?

Imvax is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 29, 2025.

MLA

"Imvax — Funding & Investors." VCBacked, January 29, 2025, https://www.vcbacked.co/company/imvax. Accessed July 2, 2026.

APA

VCBacked. (2025). Imvax — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/imvax

Wikipedia (cite web)

{{cite web |title=Imvax — Funding & Investors |url=https://www.vcbacked.co/company/imvax |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 29, 2025.